Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P110038/S033

RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM

Bolton Medical, Inc. · Decision date Oct 10, 2025

FDA DECISIONP110038/S033

What did the FDA approve?

FDA records P110038/S033 as a supplement to PMA P110038, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Oct 10, 2025.

FDA approval order statement

approval for labeling updates to include the final study results of the Relay Thoracic Stent-Graft with Plus Delivery System Pivotal, Continued Access, and Post Approval Studies
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Oct 10, 2025
FDA change category
Labeling Change - PAS

FDA source record

Regulatory record facts

Identifier
P110038/S033
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
APPR
Decision date
Oct 10, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P110038/S033 received

    Application receipt date recorded by FDA.

  2. P110038/S033 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P110038. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P110038

Product / regulatory recordCompanyPathwayDecision dateSource
RelayPlusP110038/S034
Bolton Medical, Inc.PMA supplementSep 3, 2025FDA

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bolton Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
799 International Pkwy., Sunrise, FL, 33325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records